Advances in Post-Kidney Transplant Immunosuppression: Applying the Latest CNI-Sparing Strategies to Optimize Long-Term Outcomes

While calcineurin inhibitors (CNIs) have long served as the cornerstone of maintenance immunosuppression following kidney transplantation, a growing body of evidence supports the use of alternative regimens that include co-stimulation blockade or mTOR inhibitors, to reduce adverse events and improve long-term graft function in select patients. Join us for this live symposium offered in conjunction with the World Transplant Congress 2025, featuring two renowned kidney transplant experts. Together they will discuss how to individualize maintenance immunosuppression regimens and apply the latest CNI-sparing strategies in practice. This highly interactive session will spotlight complex cases and practical tools, including a new expert-developed clinical resource, for using alternative regimens to optimize outcomes following kidney transplant. Don't miss this opportunity to learn from top thought leaders and leave with real-world strategies for use in your own clinical practice.